![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shaanxi Hanjiang Pharmaceutical Group Co. Ltd Hanzhong City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Cinnarizine, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2001-130 - Rev 01
This Chemical Type CEP, issued on December 03, 2004, remains in force until January 26, 2009, ensuring its reliability within the pharmaceutical industry.
Substance Number 816 associated with this CEP further emphasizes